Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations
As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.
In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.
A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources
Recent Posts
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chronic Disease Medicat...
Medicare drug price negotiations are transforming access to affordable healthcare for seniors, and if you're wondering how these negotiations will lower costs for high-expense cancer and chronic disease treatments, the answer is clear. Starting January 1, 2027, the Centers for Medicare & Medi...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Research
Advancing EU Clinical Trial Efficiency Through FAST-EU Trials
The FAST-EU clinical trials initiative, launched by a coalition of National Competent Authorities (NCAs) and Ethics Committees across the European Union/Europ...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Advancements in CGM for Type 2 Diabetes Management
A recent JAMA Insights article, explores the integration of continuous glucose monitoring as a complementary tool to traditional hemoglobin A1c (HbA1c) an...